Diabetes Risk Assessment with Blood Parameters of The First Degree Relatives of Patients with Type-2 Diabetes Mellitus

MakaleAçık Erişim
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Objective: This study was conducted to evaluate the diabetes risk in first degree relatives of Type-2 diabetic patients who were not diagnosed with diabetes and test the validity of the Finnish Diabetes Risk Score (FINDRISK) in determining the risk of type-2 diabetes. Methods: First degree relatives of patients who were hospitalized in Izmir Katip Celebi University Ataturk Training and Research Hospital, who were not diagnosed with diabetes before, were included in this cross-sectional study. The sample of the research consisted of 200 people determined by power analysis. Data were collected by a structured question form and the FINRISK scale. Participants' height, weight, waist circumference were measured by the researcher, and venous fasting blood glucose (FBG) with Glycosylated Hemoglobin (HbA1c) were taken by the researcher. Results: The average age of the participants was 46.93 +/- 14.83 (18-86). It was determined that the vast majority of the individuals participating in the study were female (65%), 63% were married, 50.5% received high school or higher education, and 59% worked in an income-generating job. The findings was indicated that 41.5% of the participants were in the 'high-risk group' for type-2 diabetes according to the FINDRISK score scale. Sensitivity of FINDRISK score to FBG was 100% and specificity was 60%. Conclusion: As a result of findings in this study indicate that It was determined that the risk of DM was high in the first degree relatives of the patients hospitalized with Type-2 DM and the FINDRISK score scale was a good scale in predicting new asymptomatic Type 2 diabetes.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/gumushane/16066Resmi atıflarda kullanılan kalıcı adres
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
WoS
1
OpenAlex
1
TR Dizin
2
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDemirag, Hatice
dc.contributor.authorBoyraz, Sakine
dc.date.accessioned2026-10-22T10:26:22.794499642Z
dc.date.available2026-10-22T10:26:22.794499642Z
dc.date.issued2021-03
dc.description.abstractObjective: This study was conducted to evaluate the diabetes risk in first degree relatives of Type-2 diabetic patients who were not diagnosed with diabetes and test the validity of the Finnish Diabetes Risk Score (FINDRISK) in determining the risk of type-2 diabetes. Methods: First degree relatives of patients who were hospitalized in Izmir Katip Celebi University Ataturk Training and Research Hospital, who were not diagnosed with diabetes before, were included in this cross-sectional study. The sample of the research consisted of 200 people determined by power analysis. Data were collected by a structured question form and the FINRISK scale. Participants' height, weight, waist circumference were measured by the researcher, and venous fasting blood glucose (FBG) with Glycosylated Hemoglobin (HbA1c) were taken by the researcher. Results: The average age of the participants was 46.93 +/- 14.83 (18-86). It was determined that the vast majority of the individuals participating in the study were female (65%), 63% were married, 50.5% received high school or higher education, and 59% worked in an income-generating job. The findings was indicated that 41.5% of the participants were in the 'high-risk group' for type-2 diabetes according to the FINDRISK score scale. Sensitivity of FINDRISK score to FBG was 100% and specificity was 60%. Conclusion: As a result of findings in this study indicate that It was determined that the risk of DM was high in the first degree relatives of the patients hospitalized with Type-2 DM and the FINDRISK score scale was a good scale in predicting new asymptomatic Type 2 diabetes.
dc.identifier.doi10.33808/clinexphealthsci.655688
dc.identifier.eissn2459-1459
dc.identifier.endpage157
dc.identifier.issn2459-1459
dc.identifier.issue1
dc.identifier.startpage151
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/16066
dc.identifier.volume11
dc.identifier.wosWOS:000636479400023
dc.language.isoen
dc.publisherMARMARA UNIV, INST HEALTH SCIENCES
dc.relation.ispartofCLINICAL AND EXPERIMENTAL HEALTH SCIENCES
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRisk for diabetes
dc.subjectFINDRISK
dc.subjecttype 2 DM
dc.subjectFBG
dc.subjectHbA1c
dc.subject.classificationMedicine, Research & Experimental
dc.subject.classificationResearch & Experimental Medicine
dc.subject.otherFAMILY-HISTORY
dc.subject.otherINDIVIDUALS
dc.titleDiabetes Risk Assessment with Blood Parameters of The First Degree Relatives of Patients with Type-2 Diabetes Mellitus
dc.typeArticle
rdl.citation.openalex1
rdl.citation.trdizin2
rdl.citation.wos1
rdl.oa.statusbronze
rdl.oa.urlhttps://dergipark.org.tr/en/download/article-file/874543
rdl.sdgSDG03
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexEmerging Sources Citation Index (ESCI)